USP's Therapeutic Peptides Expert Panel discusses manufacturing processes and impurity control for synthetic peptide APIs.
Brian Gregg
Advertisement
Brian Gregg is chief operating officer at Bachem Americas.
Articles by Brian Gregg
USP evaluates raw materials used in the chemical synthesis of peptides.
USP evaluates quality attributes for synthetic peptides.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Is Compliant AI in Pharma Even Possible? The Search for an Honest Answer
3
Sustainability by Design: Re-Imagining Amorphous Dispersion Manufacturing
4
Why the First Generic Single-Dose Flu Antiviral Approval Matters
5